Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × Artesunate × Clear all

Phase

Status

Unknown 2 Not yet recruiting 2 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

pembrolizumab 371 Carboplatin 268 Cyclophosphamide 260 Nivolumab 253 Paclitaxel 212 Cisplatin 202 Specimen Handling 200 Magnetic Resonance Spectroscopy 197 Radiotherapy 179 Dexamethasone 158 Gemcitabine 152 durvalumab 150 Biopsy 140 atezolizumab 132 Lenalidomide 123 Rituximab 118 Doxorubicin 116 Docetaxel 115 Bevacizumab 114 Ipilimumab 109 Oxaliplatin 101 Capecitabine 99 Radiosurgery 98 Radiation 98 fludarabine 97 Fluorouracil 96 Etoposide 94 venetoclax 93 Prednisone 93 Pemetrexed 90

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡